期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
依那普利联合苯磺酸氨氯地平治疗高血压疗效观察 被引量:6
1
作者 李嫦为 《基层医学论坛》 2013年第32期4255-4256,共2页
目的观察依那普利联合苯磺酸氨氯地平治疗高血压的疗效。方法选择37例患者分为对照组17例和观察组20例,2组患者均给予相同剂量的苯磺酸氨氯地平进行治疗,观察组同时给予依那普利,2组疗程均为2个月。2个月后观察2组疗效和不良反应。结果... 目的观察依那普利联合苯磺酸氨氯地平治疗高血压的疗效。方法选择37例患者分为对照组17例和观察组20例,2组患者均给予相同剂量的苯磺酸氨氯地平进行治疗,观察组同时给予依那普利,2组疗程均为2个月。2个月后观察2组疗效和不良反应。结果观察组总有效率为95%,对照组总有效率为76.5%,观察组总有效率明显高于对照组(P<0.05),且观察组发生不良反应明显低于对照组(P<0.05)。结论依那普利联合苯磺酸氨氯地平治疗高血压的疗效优于单独使用苯磺酸氨氯地平,联合治疗高血压值得在临床上推广使用。 展开更多
关键词 高血压依那普利 苯磺酸氨氯地平 联合 治疗
下载PDF
依那普利联合非洛地平治疗糖尿病肾病疗效观察
2
作者 贺绍纲 李君慧 《临床和实验医学杂志》 2007年第6期38-39,共2页
目的观察依那普利联合非洛地平治疗糖尿病肾病的降压效果和肾功能保护作用。方法采用随机分组对照法将87例糖尿病肾病患者分为两组,治疗组44例给予依那普利片10mg加非洛地平缓释片5mg,1次/d;对照组43例给予非洛地平缓释片5mg1次/d加美... 目的观察依那普利联合非洛地平治疗糖尿病肾病的降压效果和肾功能保护作用。方法采用随机分组对照法将87例糖尿病肾病患者分为两组,治疗组44例给予依那普利片10mg加非洛地平缓释片5mg,1次/d;对照组43例给予非洛地平缓释片5mg1次/d加美托洛尔片50mmg,2次/d,疗程均为12个月。结果治疗组降压总有效率高于对照组(P<0.01),治疗后尿蛋白低于治疗前(P<0.01),血肌酐、尿素氮治疗前后无显著差异,但治疗后低于对照组(P<0.05)。结论依那普利联合非洛地平治疗糖尿病肾病,不但能有效控制高血压,并具有显著的肾功能保护作用。 展开更多
关键词 糖尿病肾病 肾功能 高血压依那普利 非洛地平
下载PDF
马来酸依那普利叶酸片对H型高血压左心室肥厚患者血浆Hcy水平及心功能的影响 被引量:6
3
作者 穆珍珍 黄焯明 《黑龙江中医药》 2018年第5期115-116,共2页
目的:研究马来酸依那普利叶酸片对H型高血压左室肥厚病人血水平和心功能的影响。方法:选取2017年1月至2018年1月收入我院的该类病患120例当做此次课题研究目标,将他们均分为治疗组以及对照组。对后者口服马来酸依那普利片,治疗组口服马... 目的:研究马来酸依那普利叶酸片对H型高血压左室肥厚病人血水平和心功能的影响。方法:选取2017年1月至2018年1月收入我院的该类病患120例当做此次课题研究目标,将他们均分为治疗组以及对照组。对后者口服马来酸依那普利片,治疗组口服马来酸依那普利叶酸片,两组均治疗12月,记录治疗前后血浆同型半胱氨酸(Hcy)、左室射血分数(LVEF)、早期与晚期二尖瓣血流峰速比值(E/A)的差异。结果:治疗后,患者收缩压、舒张压及血浆Hcy水平较治疗前均明显下降(P <0.01),患者二尖瓣血流峰速度(LVEF)值较前均升高(P <0.05)。结论:马来酸依那普利叶酸片可以有效地降低该类患者血Hcy水平,改善左室的舒张及收缩功能。 展开更多
关键词 马来酸依那普利叶酸片H型高血压 左心室肥厚 血浆同型半胱氨酸 心功能
原文传递
Role of TGF-β1/Smads pathway in carotid artery remodeling in renovascular hypertensive rats and prevention by Enalapril and Amlodipine 被引量:2
4
作者 Jian-Ling Chen Qian-Hui Shang +3 位作者 Wei Hu Chan Liu Wan-Heng Mao Hua-Qing Liu 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2012年第2期185-191,共7页
Objective To investigate the role of transforming growth factor-β1 (TGF-β1), Smad2/3 and Smad7 expressions in carotid artery remodeling in renovascular hypertensive rats, and also the therapeutic effect of Enalapr... Objective To investigate the role of transforming growth factor-β1 (TGF-β1), Smad2/3 and Smad7 expressions in carotid artery remodeling in renovascular hypertensive rats, and also the therapeutic effect of Enalapril and Amlodipine. Methods The renovascular hypertensive rat (RHR) models with "two-kidney and one-clip" were established, including model group (n = 6), sham-operated group (n = 6), Enalapril group (10 mg/kg per day, n = 6), Amlodipine group (5 mg/kg per day, n = 6) and combination group (Amlodipine 2.5 mg/kg per day + Enalapril 5mg/kg per day, n = 6). The medication were continuous administrated for six weeks. Carotid artery morphological and structural changes in the media were observed by HE staining, Masson staining and immuno histochemical staining. Media thickness (MT), MT and lumen diameter ratio (MT/LD), and the expression levels of media a-smooth muscle actin (α-actin), proliferating cell nuclear antigen (PCNA), TGF-β1, phosphorylated Smad2/3 (p-Smad2/3) and Smad7 in carotid arteries were measured. Results The media of carotid arteries in RHR model group was significantly thickened, the volume of smooth muscle cell was increased, and the array was in disorder; MT, MT/LD, the proliferation index of smooth muscle cell and collagen fiber area percentage of carotid arteries in the model group were significantly higher than those in the sham-operated group (P 〈 0.01). Compared to sham-operated group, the model group had significantly higher expressions of TGF-β1 and p-Smad2/3 (P 〈 0.05) and lower Smad7 expression. Both Enalapril and Amlodipine improved smooth muscle hypertrophy and collagen deposition, reduced RHR carotid MT, MT/LD, proliferation index of smooth muscle cell, collagen fiber area percentage and the expressions of TGF-β1 and p-Smad2/3 (P 〈 0.05), increased Smad7 expression (P 〈 0.05). Moreover, the combination treatment of Enalapril and Amlodipine had significantly better effects than single Amlodipine group (P 〈 0.05), but not single Enalapril group. Conclusions TGF-β1/Smads pathway may participate in the mechanism of carotid artery remodeling in RHR; the role of Amlodipine and Enalapril in inversing carotid artery remodeling may be related to the change of TGF-β1/Smads pathway, the combination treatment of Amlodipine and Enalapril had better effects than single administration of Amlodipine. 展开更多
关键词 HYPERTENSION Vascular remodeling Transforming growth factor-β1 P-SMAD2/3 SMAD7 ENALAPRIL AMLODIPINE
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部